Iowa Doctors Hesitant to Certify Medical Cannabis Patients
https://pixabay.com/en/marijuana-colorado-marijuana-grow-269851/

Iowa Doctors Hesitant to Certify Medical Cannabis Patients

According to the Des Moines Register, Iowa has a new medical marijuana program rolling out on December 1st, but many doctors in the state have reservations about enrolling patients. Iowa's…

Continue Reading Iowa Doctors Hesitant to Certify Medical Cannabis Patients

Research Highlights Link Between Kidney Disease and Alstrom Syndrome

According to a story from uhb.nhs.uk, a recent study has drawn a link between chronic kidney disease and Alström syndrome. The research team is associated with the University Hospitals Birmingham…

Continue Reading Research Highlights Link Between Kidney Disease and Alstrom Syndrome

Working to Improve Gene Therapy for Adrenoleukodystrophy and Other Rare Conditions

Rare disease research is often underrepresented in the field of science. However, recent developments have made researchers more interested in studying this group of diseases. For instance, investments in gene…

Continue Reading Working to Improve Gene Therapy for Adrenoleukodystrophy and Other Rare Conditions
First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA
frolicsomepl / Pixabay

First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA

According to a story from BioSpace, the biopharmaceutical company Sobi and the biotechnology company NovImmune SA have recently announced that the US Food and Drug Administration (FDA) has approved Gamifant,…

Continue Reading First Treatment for Hemophagocytic Lymphohistiocytosis is Approved by the FDA
Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
Source: Pixabay.com

Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease

According to a story from the biotechnology company Amgen, a review from the European Medicines Agency (EMA) has recommended that the indication for blinatumomab, marketed as BLINCYTO®, be expanded. The…

Continue Reading Treatment Used for Acute Lymphoblastic Leukemia Expanded to Patients with Minimal Residual Disease
Close Menu